Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $136.0400 (3.12%) ($136.0400 - $136.3800) on Wed. Sep. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.01% (three month average) | RSI | 76 | Latest Price | $136.0400(3.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.5% a day on average for past five trading days. | Weekly Trend | LGND advances 12.5% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) IWM(56%) IWC(53%) IWN(51%) | Factors Impacting LGND price | LGND will decline at least -1.505% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-16%) IGOV(-6%) UNG(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.505% (StdDev 3.01%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $136.97(-0.68%) | 10 Day Moving Average | $128.35(5.99%) | 20 Day Moving Average | $118.78(14.53%) | To recent high | -2.7% | To recent low | 32.8% | Market Cap | $2.186b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |